Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients

por de Vos, Luka, Gevensleben, Heidrun, Schröck, Andreas, Franzen, Alina, Kristiansen, Glen, Bootz, Friedrich, Dietrich, Dimo
Publicado en Clin Epigenetics (2017)

PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma

por Sailer, Verena, Holmes, Emily Eva, Gevensleben, Heidrun, Goltz, Diane, Dröge, Freya, Franzen, Alina, Dietrich, Jörn, Kristiansen, Glen, Bootz, Friedrich, Schröck, Andreas, Dietrich, Dimo
Publicado en Clin Epigenetics (2017)

PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas

por Franzen, Alina, Vogt, Timo J., Müller, Tim, Dietrich, Jörn, Schröck, Andreas, Golletz, Carsten, Brossart, Peter, Bootz, Friedrich, Landsberg, Jennifer, Kristiansen, Glen, Dietrich, Dimo
Publicado en Oncotarget (2017)

Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression

por von Mässenhausen, Anne, Brägelmann, Johannes, Billig, Hannah, Thewes, Britta, Queisser, Angela, Vogel, Wenzel, Kristiansen, Glen, Schröck, Andreas, Bootz, Friedrich, Brossart, Peter, Kirfel, Jutta, Perner, Sven
Publicado en Int J Mol Sci (2016)

PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma

por Sailer, Verena, Holmes, Emily Eva, Gevensleben, Heidrun, Goltz, Diane, Dröge, Freya, de Vos, Luka, Franzen, Alina, Schröck, Friederike, Bootz, Friedrich, Kristiansen, Glen, Schröck, Andreas, Dietrich, Dimo
Publicado en Oncotarget (2016)

PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma

por Müller, Tim, Braun, Martin, Dietrich, Dimo, Aktekin, Seher, Höft, Simon, Kristiansen, Glen, Göke, Friederike, Schröck, Andreas, Brägelmann, Johannes, Held, Stefanie A.E., Bootz, Friedrich, Brossart, Peter
Publicado en Oncotarget (2017)

Sex Determining Region Y-Box 2 (SOX2) Amplification Is an Independent Indicator of Disease Recurrence in Sinonasal Cancer

por Schröck, Andreas, Göke, Friederike, Wagner, Patrick, Bode, Maike, Franzen, Alina, Braun, Martin, Huss, Sebastian, Agaimy, Abbas, Ihrler, Stephan, Menon, Ropika, Kirsten, Robert, Kristiansen, Glen, Bootz, Friedrich, Lengerke, Claudia, Perner, Sven
Publicado 2013

MERTK as a novel therapeutic target in head and neck cancer

por von Mässenhausen, Anne, Sanders, Christine, Thewes, Britta, Deng, Mario, Queisser, Angela, Vogel, Wenzel, Kristiansen, Glen, Duensing, Stefan, Schröck, Andreas, Bootz, Friedrich, Brossart, Peter, Kirfel, Jutta, Heasley, Lynn, Brägelmann, Johannes, Perner, Sven
Publicado en Oncotarget (2016)

MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy

por Laban, Simon, Giebel, Gregor, Klümper, Niklas, Schröck, Andreas, Doescher, Johannes, Spagnoli, Giulio, Thierauf, Julia, Theodoraki, Marie-Nicole, Remark, Romain, Gnjatic, Sacha, Krupar, Rosemarie, Sikora, Andrew G., Litjens, Geert, Grabe, Niels, Kristiansen, Glen, Bootz, Friedrich, Schuler, Patrick J., Brunner, Cornelia, Brägelmann, Johannes, Hoffmann, Thomas K., Perner, Sven
Publicado en Oncotarget (2017)